SCHEMBL6589098

SCHEMBL6589098

CN1CCC(n2ccc3cc(F)ccc32)CC1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.54
HTR1D P28221 1/20 0.54
HTR1B P28222 1/20 0.54
HTR1F P30939 1/20 0.54
HTR7 P34969 3/20 0.54
HTR2A P28223 2/20 0.54
KCNH2 Q12809 1/20 0.54
NOS3 P29474 3/20 0.48
NOS1 P29475 3/20 0.48
NOS2 P35228 3/20 0.48
SCD O00767 9/20 0.47
DRD2 P14416 1/20 0.46
SLC6A4 P31645 1/20 0.46
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
HTR3A P46098 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28839286 0.87 HTR2A (0.48) HTR1AHTR1DHTR1BHTR1FHTR7
SCHEMBL31434301 0.84 HTR2A (0.45) HTR1AHTR1DHTR1BHTR1FHTR7
SCHEMBL25766261 0.84 HTR2A (0.45) HTR1AHTR1DHTR1BHTR1FHTR7
SCHEMBL26408392 0.83 NOS3 (0.49) HTR1AHTR1DHTR1BHTR1FHTR7
SCHEMBL30594683 0.82 PRKCI (0.51) HTR1AHTR1DHTR1BHTR1FHTR7
SCHEMBL2266494 0.82 PRKCI (0.51) HTR1AHTR1DHTR1BHTR1FHTR7
SCHEMBL27544242 0.82 NOS3 (0.51) HTR1AHTR1DHTR1BHTR1FHTR7
SCHEMBL2264672 0.82 NOS3 (0.48) HTR1AHTR1DHTR1BHTR1FHTR7
SCHEMBL6789672 0.82 SCD (0.55) HTR1AHTR1DHTR1BHTR1FHTR7
SCHEMBL7149460 0.80 CCR3 (0.46) HTR7HTR2AKCNH2SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183252-B1 PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRAZENECA AB (SE) 2004-02-18 EP disclosed
US-6492406-B1 PROTEIN KINASE C INHIBITORS; ANTIINFLAMMATORY AND IMMUNO-SUPPRESSIVE AGENTS ASTRAZENECA AB (SE) 2002-12-10 US disclosed
CN-1351602-A Novel Pharmaceutically Active Compounds ASTRAZENECA AB (SE) 2002-05-29 CN disclosed
EP-1183252-A1 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS AstraZeneca AB (SE) 2002-03-06 EP disclosed
WO-2000071537-A1 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRAZENECA AB (SE) 2000-11-30 WO disclosed